Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May;60(5):450-457.
doi: 10.1007/s00108-019-0590-y.

[Minimal change disease and focal segmental glomerulosclerosis]

[Article in German]
J Müller-Deile  1 , H Schenk  2 , M Schiffer  3   4
Affiliations
Review

[Minimal change disease and focal segmental glomerulosclerosis]

[Article in German]
J Müller-Deile et al. Internist (Berl). 2019 May.

Abstract

Minimal change disease (MCD) or minimal change glomerulonephritis and focal segmental glomerulosclerosis (FSGS) are the two major causes of nephrotic syndrome in children and young adults. Both disease entities resemble each other and can sometimes only be discriminated on the basis of their clinical courses. MCD and FSGS display two classical examples that share a common pathophysiology in which the glomerular podocyte and the cytoskeleton of its foot processes play important roles. Therefore, the term "podocytopathy" was introduced for both diseases. In this article, we compare their differences and similarities, and summarized new data on pathophysiology and treatment. In adults, only a renal biopsy including electron microscopy allows for the discrimination of MCD and FSGS and other differential diagnoses. The identification of a primary or secondary form of the disease is based on the clinical course. Data from studies on the treatment are sparse; hence, treatment is still based on high-dose steroids followed by additional immunosuppressive agents. In secondary forms, treatment of the underlying disease is elementary.

Keywords: Biopsy, kidney; Immunosuppression; Nephrotic syndrome; Podocytes; Steroids.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Clin Apher. 2017 Dec;32(6):444-452 - PubMed
    1. J Am Soc Nephrol. 2009 Feb;20(2):260-6 - PubMed
    1. Clin J Am Soc Nephrol. 2007 May;2(3):445-53 - PubMed
    1. J Am Soc Nephrol. 2012 Aug;23(8):1319-28 - PubMed
    1. Indian J Nephrol. 2018 Jan-Feb;28(1):28-34 - PubMed

MeSH terms

LinkOut - more resources